Chronic inflammatory demyelinating polyneuropathy
Showing 26 - 50 of >10,000
CIDP - Chronic Inflammatory Demyelinating Polyneuropathy Trial in Denmark (Immunoglobulin)
Recruiting
- CIDP - Chronic Inflammatory Demyelinating Polyneuropathy
- Immunoglobulin
-
Aalborg, Denmark
- +3 more
Oct 9, 2020
Polyradiculoneuropathy, Chronic Inflammatory Demyelinating Trial in Worldwide (Nipocalimab, Placebo)
Recruiting
- Polyradiculoneuropathy, Chronic Inflammatory Demyelinating
- Nipocalimab
- Placebo
-
Los Angeles, California
- +135 more
Jan 17, 2023
Chronic Inflammatory Demyelinating Polyneuropathy, Peripheral Neuropathy, Charcot-Marie-Tooth Disease Trial in Creteil (MD1003)
Completed
- Chronic Inflammatory Demyelinating Polyneuropathy
- +5 more
-
Creteil, FranceHôpital Henri Mondor, Créteil, France
Oct 29, 2020
Autoimmune Disease, Neurologic Autoimmune Disease, Autologous Transplant Autoimmune Trial in Denver, Seattle (biological,
Recruiting
- Autoimmune Disease
- +18 more
- Anti-Thymocyte Globulin
- +9 more
-
Denver, Colorado
- +2 more
Feb 1, 2023
Fluctuations in CIDP Patients Using Daily Grip Strength
Completed
- Chronic Inflammatory Demyelinating Polyneuropathy
- Intravenous Immunoglobulin
-
Johns Creek, Georgia
- +6 more
Aug 12, 2020
Chronic Inflammatory Demyelinating Polyneuropathy (CIDP) Trial in Worldwide (efgartigimod PH20 SC in stage B, in stage B)
Recruiting
- Chronic Inflammatory Demyelinating Polyneuropathy (CIDP)
- efgartigimod PH20 SC in stage B
- placebo in stage B
-
Birmingham, Alabama
- +212 more
Jan 13, 2023
Polyradiculoneuropathy, Chronic Inflammatory Demyelinating Trial in Rozzano (Rituximab)
Active, not recruiting
- Polyradiculoneuropathy, Chronic Inflammatory Demyelinating
-
Rozzano, Milano, ItalyIstituto Clinico Humanitas
May 17, 2023
Chronic Inflammatory Demyelinating Polyradiculoneuropathy (CIDP), Multifocal Motor Neuropathy (MMN) Trial in Japan (TAK-771)
Recruiting
- Chronic Inflammatory Demyelinating Polyradiculoneuropathy (CIDP)
- Multifocal Motor Neuropathy (MMN)
-
Nagoya, Aichi, Japan
- +16 more
Feb 2, 2023
GAMMAGARD LIQUID in Chronic Inflammatory Demyelinating
Active, not recruiting
- Chronic Inflammatory Demyelinating Polyradiculoneuropathy (CIDP)
-
Durham, North CarolinaRTI Health Solutions
Jun 14, 2022
Intravenous Immunoglobulin Treatment in Chronic Inflammatory
Completed
- Chronic Inflammatory Demyelinating Polyradiculoneuropathy
-
Paris, FranceGroupe Hospitalier Paris Saint-Joseph
Mar 30, 2022
Chronic Inflammatory Demyelinating Polyradiculoneuropathy (CIDP) Trial in Worldwide (Rozanolixizumab)
Completed
- Chronic Inflammatory Demyelinating Polyradiculoneuropathy (CIDP)
-
Scottsdale, Arizona
- +13 more
Mar 31, 2022
Autoimmune Diseases, Autoimmune Diseases of the Nervous System, Neuromyelitis Optica Spectrum Disorder Trial in Wuhan (CT103A
Recruiting
- Autoimmune Diseases
- +5 more
- CT103A cells
- Cyclophosphamide and fludarabine
-
Wuhan, Hubei, ChinaTongji Hospital affiliated to Tongji Medical College of Huazhong
Dec 10, 2022
Decreased Corneal Sensation in Chronic Inflammatory
Completed
- Chronic Inflammatory Demyelinating Polyneuropathy
-
Buffalo, New YorkDent Neurological Institute
Jun 21, 2019
Peripheral Neuropathy, Chronic Inflammatory Demyelinating Polyradiculoneuropathy, Vasculitic Neuropathy (Disorder) Trial in
Active, not recruiting
- Peripheral Neuropathy
- +5 more
- Biopsy + Nerve Repair
- Biopsy Only
-
Rochester, MinnesotaMayo Clinic in Rochester
Jan 25, 2023
High Frequency Ultrasound in Demyelinating Polyneuropathies
Not yet recruiting
- Chronic Inflammatory Demyelinating Polyradiculoneuropathy
- high frequency ultrasound
-
Nice, FranceNice University Hospital
Jul 28, 2021
Predict Intravenous Immunoglobulin Responders in Chronic
Suspended
- CIDP
- CIDP treated (IVIG)
-
Bordeaux, Aquitaine, France
- +17 more
Dec 23, 2021
Healthy, Primary Immune Thrombocytopenia, Polyradiculoneuropathy, Chronic Inflammatory Demyelinating Trial in Worldwide
Recruiting
- Healthy
- +2 more
- PF-06755347 intravenous healthy participant
- +4 more
-
New Haven, Connecticut
- +5 more
Dec 29, 2022
Chronic Inflammatory Demyelinating Polyradiculoneuropathy Trial in Worldwide (HYQVIA)
Active, not recruiting
- Chronic Inflammatory Demyelinating Polyradiculoneuropathy
- HYQVIA
-
Phoenix, Arizona
- +34 more
Mar 21, 2022
Chronic Inflammatory Demyelinating Poly(Radiculo)Neuropathy Trial in Worldwide (NewGam)
Completed
- Chronic Inflammatory Demyelinating Poly(Radiculo)Neuropathy
-
Blagoevgrad, Bulgaria
- +25 more
Jan 28, 2021
Chronic Inflammatory Demyelinating Polyradiculoneuropathy Trial in Worldwide (HYQVIA, 0.25% albumin solution with rHuPH20,
Completed
- Chronic Inflammatory Demyelinating Polyradiculoneuropathy
- HYQVIA
- +2 more
-
Phoenix, Arizona
- +82 more
Feb 28, 2022
Obesity, Immune Deficiency Trial in Somerville (Institutional standard intravenous immune globulin treatment)
Recruiting
- Obesity
- Immune Deficiency
- Institutional standard intravenous immune globulin treatment
-
Somerville, New JerseyRobert Wood Johnson University Hospital Somerset
Oct 10, 2022
Cutaneous Nerve Demyelination in Diagnosis and Treatment of CIDP
Not yet recruiting
- CIDP
- IVIg
-
Nashville, TennesseeVanderbilt University
Nov 4, 2022
Immunoadsorption Versus Plasma Exchange for Treatment of
Recruiting
- GBS
- Immunoadsorption
- Plasma Exchange
-
Ulm, Baden-Württemberg, GermanyDepartment of Neurology, University of Ulm
Sep 28, 2021
Pain, Chronic Trial in Assiut (Ozone, Convtrol group)
Not yet recruiting
- Pain, Chronic
- Ozone
- Convtrol group
-
Assiut, EgyptEmad Zarief Kamel Said
Jan 4, 2022
CIDP and MMN Patients Following Initial Intravenous IVIg
Not yet recruiting
- Multifocal Motor Neuropathy (MMN)
- Chronic Inflammatory Demyelinating Polyradiculoneuropathy
- (no location specified)
Apr 30, 2020